36% of patients who received 3D conformal radiation therapy (3D-CRT) to treat their medically inoperable stage I nonsmall cell lung cancer (NSCLC) lived 5 years after diagnosis--compared to 10% who received conventional radiation therapy. In a recent study, (1) physicians at MD Anderson Cancer ...